AKT1 and cancer: The E17K mutation is mostly mutually exclusive with other PI3K/Akt pathway activating alterations26, 27 and occurs at low frequency in several human cancers that are frequently treated with radiotherapy, such as tumours of the breast, intestines, lung, and prostate3, 26, 28.